Raymond James & Associates’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.2M | Sell |
204,754
-21,503
| -10% | -$106K | ﹤0.01% | 2572 |
|
|
2024
Q2 | $975K | Sell |
226,257
-35,763
| -14% | -$171K | ﹤0.01% | 2636 |
|
|
2024
Q1 | $1.23M | Sell |
262,020
-81,192
| -24% | -$311K | ﹤0.01% | 2471 |
|
|
2023
Q4 | $1.69M | Sell |
343,212
-103,994
| -23% | -$509K | ﹤0.01% | 2201 |
|
|
2023
Q3 | $2.44M | Sell |
447,206
-231,737
| -34% | -$1.86M | ﹤0.01% | 1895 |
|
|
2023
Q2 | $6.29M | Sell |
678,943
-256,323
| -27% | -$2.17M | 0.01% | 1331 |
|
|
2023
Q1 | $7.69M | Sell |
935,266
-1,425,694
| -60% | -$15.7M | 0.01% | 1193 |
|
|
2022
Q4 | $26.3M | Sell |
2,360,960
-109,162
| -4% | -$1.27M | 0.02% | 551 |
|
|
2022
Q3 | $29.3M | Sell |
2,470,122
-49,776
| -2% | -$754K | 0.03% | 466 |
|
|
2022
Q2 | $38.5M | Buy |
2,519,898
+726,974
| +41% | +$13.1M | 0.04% | 387 |
|
|
2022
Q1 | $37.9M | Buy |
1,792,924
+289,906
| +19% | +$6.25M | 0.03% | 444 |
|
|
2021
Q4 | $35.5M | Buy |
1,503,018
+73,134
| +5% | +$1.57M | 0.03% | 496 |
|
|
2021
Q3 | $28.7M | Buy |
1,429,884
+24,347
| +2% | +$499K | 0.03% | 539 |
|
|
2021
Q2 | $28.3M | Sell |
1,405,537
-5,714
| -0.4% | -$122K | 0.03% | 542 |
|
|
2021
Q1 | $30M | Buy |
1,411,251
+7,175
| +0.5% | +$154K | 0.03% | 486 |
|
|
2020
Q4 | $30.6M | Sell |
1,404,076
-96,162
| -6% | -$1.87M | 0.03% | 446 |
|
|
2020
Q3 | $26.4M | Sell |
1,500,238
-208,655
| -12% | -$3.88M | 0.03% | 446 |
|
|
2020
Q2 | $32.1M | Buy |
1,708,893
+4,038
| +0.2% | +$71.5K | 0.04% | 356 |
|
|
2020
Q1 | $29.5M | Buy |
1,704,855
+32,943
| +2% | +$689K | 0.05% | 326 |
|
|
2019
Q4 | $35.3M | Buy |
1,671,912
+83,795
| +5% | +$1.7M | 0.04% | 365 |
|
|
2019
Q3 | $31.1M | Buy |
1,588,117
+244,251
| +18% | +$4.49M | 0.04% | 388 |
|
|
2019
Q2 | $23.4M | Buy |
1,343,866
+235,682
| +21% | +$4.24M | 0.03% | 488 |
|
|
2019
Q1 | $20.5M | Buy |
1,108,184
+188,504
| +20% | +$3.36M | 0.03% | 514 |
|
|
2018
Q4 | $14.8M | Sell |
919,680
-646,136
| -41% | -$10.2M | 0.03% | 586 |
|
|
2018
Q3 | $23.3M | Buy |
1,565,816
+87,231
| +6% | +$1.27M | 0.04% | 475 |
|
|
2018
Q2 | $20.8M | Sell |
1,478,585
-11,309
| -0.8% | -$150K | 0.03% | 488 |
|
|
2018
Q1 | $19.4M | Sell |
1,489,894
-117,633
| -7% | -$1.51M | 0.03% | 486 |
|
|
2017
Q4 | $22.2M | Buy |
1,607,527
+625,766
| +64% | +$8.46M | 0.04% | 428 |
|
|
2017
Q3 | $12.9M | Sell |
981,761
-12,068
| -1% | -$155K | 0.03% | 614 |
|
|
2017
Q2 | $12.8M | Buy |
993,829
+96,645
| +11% | +$1.29M | 0.03% | 600 |
|
|
2017
Q1 | $11.6M | Buy |
897,184
+270,536
| +43% | +$3.46M | 0.03% | 594 |
|
|
2016
Q4 | $7.71M | Buy |
626,648
+188,932
| +43% | +$2.44M | 0.02% | 760 |
|
|
2016
Q3 | $6.46M | Buy |
437,716
+53,689
| +14% | +$812K | 0.02% | 821 |
|
|
2016
Q2 | $5.84M | Sell |
384,027
-19,981
| -5% | -$283K | 0.02% | 774 |
|
|
2016
Q1 | $5.24M | Sell |
404,008
-2,472
| -0.6% | -$28.2K | 0.02% | 796 |
|
|
2015
Q4 | $4.68M | Sell |
406,480
-9,703
| -2% | -$111K | 0.02% | 833 |
|
|
2015
Q3 | $4.6M | Buy |
416,183
+10,146
| +2% | +$126K | 0.02% | 793 |
|
|
2015
Q2 | $5.32M | Buy |
406,037
+114,656
| +39% | +$1.6M | 0.02% | 783 |
|
|
2015
Q1 | $4.29M | Buy |
291,381
+86,531
| +42% | +$1.29M | 0.02% | 827 |
|
|
2014
Q4 | $2.82M | Buy |
204,850
+32,683
| +19% | +$438K | 0.01% | 970 |
|
|
2014
Q3 | $2.11M | Buy |
172,167
+25,284
| +17% | +$336K | 0.01% | 1075 |
|
|
2014
Q2 | $1.95M | Buy |
146,883
+10,425
| +8% | +$138K | 0.01% | 1106 |
|
|
2014
Q1 | $1.75M | Buy |
136,458
+29,019
| +27% | +$373K | 0.01% | 1112 |
|
|
2013
Q4 | $1.31M | Buy |
107,439
+3,254
| +3% | +$41.6K | 0.01% | 1173 |
|
|
2013
Q3 | $1.27M | Sell |
104,185
-1,874
| -2% | -$25K | 0.01% | 1115 |
|
|
2013
Q2 | $1.52M | Buy |
+106,059
| New | +$1.67M | 0.01% | 949 |
|
Other funds holding MPT
SPC
Raymond James & Associates's MPT Position: Q3 2024 in Review
Raymond James & Associates reduced its Medical Properties Trust (MPT) stake by 9.5% in Q3 2024, selling an estimated $106K and leaving 204,754 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2572.
Raymond James & Associates first reported a position in MPT in Q2 2013 and has held it in 46 quarters since. The position peaked at $38.5M in Q2 2022. 506 funds tracked by Wall St. Rank hold MPT as of Q3 2024.
- Raymond James & Associates held 204,754 shares of Medical Properties Trust worth $1.2M as of Q3 2024.
- Raymond James & Associates sold 21,503 Medical Properties Trust shares in Q3 2024, an estimated $106K.
- Medical Properties Trust made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2572 holding.
- Raymond James & Associates first reported a position in Medical Properties Trust in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's Medical Properties Trust position peaked at $38.5M in Q2 2022.
- 506 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.